MedPath

Multiple-center randomized controlled clinical study of electroacupuncture relieving primary dysmenorrhea

Not Applicable
Not yet recruiting
Conditions
primary dysmenorrhea
Registration Number
ITMCTR2100005394
Lead Sponsor
The First Affiliated Hospital ,University of South China
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) Meet the diagnostic criteria of primary dysmenorrhea
(2) Age ranged from 14 to 35 years old.
(3) Basic rules of the menstrual cycle (28 ±, 7 days).
(4) Designers who volunteered to participate in the clinical study signed an informed consent, did not have other treatment for dysmenorrhea within 1 month before the acupuncture treatment, and did not take NSAoidal anti-inflammatory drugs and painkillers within the first 2 weeks of the electric needle.
(5) Willing to cooperate with the treatment operation, examination and efficacy evaluation, and did not participate in other clinical experiments.
(6) Average pain visual simulation score (VisualAnalogueScale, VAS) for 4cm.
(7) Sign the informed consent form.
The above 7 simultaneous applicants can only be included in the test.

Exclusion Criteria

(1) After examination, western medicine is diagnosed as a secondary dysmenorrhea caused by uterine fibroids, adenomysiosis, endometriosis, pelvic inflammation, internal foreign body, ovarian lesions and other organic lesions.
(2) Menstrual period is successively irregular.
(3) Patients with serious cardiovascular and cerebrovascular diseases, serious diabetes mellitus, serious infection, liver and renal insufficiency, hematopoietic diseases, AIDS, and tuberculosis, hepatitis and other infectious diseases.
(4) People with obvious mental illness and obvious cognitive dysfunction.
(5) Pregnancy or pregnancy, lactation and postpartum within 1 year.
(6) Those who are participating in other clinical trials.
Note: Studies were excluded for any one of the above compliance

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.